Literature DB >> 20807566

CK2 inhibition induces apoptosis via the ER stress response.

Andrea Hessenauer1, Carolin C Schneider, Claudia Götz, Mathias Montenarh.   

Abstract

Protein kinase CK2 is a ubiquitously expressed serine/threonine kinase consisting of two catalytic α/α' and two regulatory β subunits. Expression of CK2 is highly elevated in tumor cells where it protects cells from apoptosis. Accordingly inhibition of CK2 is known to induce programmed cell death, making it a promising target for cancer therapy. In the present study we investigated apoptosis induction by the CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) in prostate tumor cells. In contrast to PC-3 cells LNCaP cells respond to CK2 inhibition with apoptosis. Most interestingly we found the mitochondrial pathway induced in LNCaP as well as in PC-3 cells as monitored by down-regulation of bcl-2 and subsequent cytochrome c release. In both cell lines activation of caspase 9 was not detected. Instead, an activation of the endoplasmic reticulum (ER) stress response in LNCaP cells after treatment with the CK2 inhibitor TBB was found. We show that this ER stress response led to an up-regulation of the death receptor DR5 and subsequent apoptosis in LNCaP cells.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807566     DOI: 10.1016/j.cellsig.2010.08.014

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  19 in total

1.  Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines.

Authors:  Carolin C Schneider; Claudia Götz; Andrea Hessenauer; Jürgen Günther; Sabine Kartarius; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

2.  Nuclear extracellular signal-regulated kinase 1 and 2 translocation is mediated by casein kinase 2 and accelerated by autophosphorylation.

Authors:  Alexander Plotnikov; Dana Chuderland; Yael Karamansha; Oded Livnah; Rony Seger
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

3.  Protein kinase CK2 impact on intracellular calcium homeostasis in prostate cancer.

Authors:  Muhammad Afzal; Betsy T Kren; A Khaliq Naveed; Janeen H Trembley; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2020-05-20       Impact factor: 3.396

Review 4.  Mechanisms of mitochondrial respiratory adaptation.

Authors:  Christopher F Bennett; Pedro Latorre-Muro; Pere Puigserver
Journal:  Nat Rev Mol Cell Biol       Date:  2022-07-08       Impact factor: 94.444

Review 5.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

Review 6.  The endoplasmic reticulum stress response in prostate cancer.

Authors:  Claire M de la Calle; Kevin Shee; Heiko Yang; Peter E Lonergan; Hao G Nguyen
Journal:  Nat Rev Urol       Date:  2022-09-27       Impact factor: 16.430

7.  MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.

Authors:  Yansong Bian; Jiawei Han; Vishnu Kannabiran; Suresh Mohan; Hui Cheng; Jay Friedman; Luo Zhang; Carter VanWaes; Zhong Chen
Journal:  Int J Biol Sci       Date:  2015-02-23       Impact factor: 6.580

8.  Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells.

Authors:  Sabrina Manni; Alessandra Brancalion; Elisa Mandato; Laura Quotti Tubi; Anna Colpo; Marco Pizzi; Rocco Cappellesso; Fortunato Zaffino; Speranza Antonia Di Maggio; Anna Cabrelle; Filippo Marino; Renato Zambello; Livio Trentin; Fausto Adami; Carmela Gurrieri; Gianpietro Semenzato; Francesco Piazza
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

9.  CK2-NCoR signaling cascade promotes prostate tumorigenesis.

Authors:  Jung-Yoon Yoo; Beom Jin Lim; Hyo-Kyoung Choi; Soon Won Hong; Ho Sung Jang; Changsoo Kim; Kyung-Hee Chun; Kyung-Chul Choi; Ho-Geun Yoon
Journal:  Oncotarget       Date:  2013-07

10.  Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M.

Authors:  Kwang Sup So; Cheol Hyeon Kim; Jin Kyung Rho; Sun Ye Kim; Yun Jung Choi; Joon Seon Song; Woo Sung Kim; Chang Min Choi; Young Jin Chun; Jae Cheol Lee
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.